Boston ScientificMEX:BSX -1.65%85 FCF Yield % is 5.02 as of Jun. 29, 2026, which is 179% above its 10-year median of 1.80. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,852.47 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Boston Scientific ranks better than 81.26% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Boston Scientific's FCF Yield % or its related term are showing as below:
MEX:BSX'
s FCF Yield % Range Over the Past 10 Years
Min: -0.37 Med: 1.8 Max: 5.02
Current: 5.02
During the past 13 years, the highest FCF Yield % of Boston Scientific was 5.02%. The lowest was -0.37%. And the median was 1.80%.
MEX:BSX's FCF Yield % is ranked better than 81.26% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs MEX:BSX: 5.02
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Boston Scientific FCF Yield % Related Terms
Boston Scientific FCF Yield % Historical Data
* Premium members only.
The historical data trend for Boston Scientific's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boston Scientific's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Boston Scientific's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a FCF Yield % of 5.02 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Boston Scientific and its competitors. This is 179% above median its historical median of 1.80. According to the industry distribution chart, Boston Scientific ranks #160 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 18.7%.
Is Boston Scientific's FCF Yield % too high?
Boston Scientific's current FCF Yield % of 5.02 is 179% above median its 10-year median of 1.80. Based on the distribution chart, Boston Scientific ranks #160 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's FCF Yield % compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #160 out of 854 companies for FCF Yield %. This places Boston Scientific in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Boston Scientific and its competitors. Boston Scientific's current FCF Yield % is 5.02, which is 179% above median its own 10-year median of 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,852.47, compared to a current price of MXN777.00 — trading 58.1% below its estimated fair value. The current FCF Yield % is 5.02, which is 179% above median its 10-year median of 1.80. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current FCF Yield % is 5.02 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN777.00 is trading 58.1% below its estimated GF Value™ of MXN1,852.47.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
FCF Yield %: 5.02 (179% above median its 10-year median of 1.80)
GF Value™: MXN1,852.47 vs. price of MXN777.00 (58.1% below fair value)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score
Get the complete analysis for MEX:BSX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
